HQ_Med_Drugs_GTE_(PH NO.: 10061) MONOCOMPONENT INSULIN RECOMBINANT DNA ORIGIN 25% INSULIN LISPRO AND 75% INSULIN LISPRO PROTAMINE SUSPENSION - 100 IU/ ML - 3 ML - PENFILLS/ CARTRIDGES (1 free Pen per 45 penfills)
STORES/SOUTH CENTRAL RLY · Pharmaceuticals · open
Key facts
- EMD: ₹1.3L
- Published: 07 Aug 2026
- Closing date: 31 Aug 2026
- Status: open
Description
Tender for supply of monocomponent insulin recombinant DNA origin, 25% insulin lispro and 75% insulin lispro protamine suspension, 100 IU/ml, 3 ml penfills/cartridges, with specified quantities and delivery schedule, by South Central Railway stores.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
- Documents required: Manufacture or authorized importer license, Supply proof of last 3 years
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Single Packet
- Evaluation: Itemwise/Consigneewise
- Make in India (MII): No
- MSE preference: No
Line items (1)
- Monocomponent Insulin Recombinant DNA Origin 25% Insulin Lispro and 75% Insulin Lispro Protamune Suspension — Qty: 82500 penfill
8 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals